Multiple sclerosis treatment biotech stock TG Therapeutics (TGTX) is Monday's IBD 50 Growth Stocks To Watch selection. The stock is clawing back from a sharp drop earlier this month, and Wall Street is expecting to see explosive earnings growth in upcoming quarters. TG Therapeutics holds the No. 4 spot in the IBD 50 behind Travere Therapeutics (TVTX), Eton Pharmaceuticals (ETON) and…
Extract — continue reading at the source.
Related stories
NYC Grocery Lawsuit Puts Subsidized Retail Space at Risk
Ford Goes All In on Bronco With Massive Portfolio Refresh Planned
The Fed's Preferred Inflation Gauge Came In Slightly Hotter Than Expected. Here's What Investors Need to Know
JPMorgan Eases SpaceX Lending Rules to Capture AI Wealth
DeFi Development Launches Real-Time Solana Data Platform
JPMorgan Weighs Stablecoin as Bank Push Accelerates